In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Insulet Corporation (NASDAQ: PODD) closed the day trading at $344.92 up 1.48% from the previous closing price of $339.88. In other words, the price has increased by $1.48 from its previous closing price. On the day, 0.78 million shares were traded. PODD stock price reached its highest trading level at $350.0 during the session, while it also had its lowest trading level at $334.91.
Ratios:
For a better understanding of PODD, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 21.65 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 61.42. For the most recent quarter (mrq), Quick Ratio is recorded 1.79 and its Current Ratio is at 2.23. In the meantime, Its Debt-to-Equity ratio is 0.97 whereas as Long-Term Debt/Eq ratio is at 0.64.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on June 16, 2025, initiated with a Buy rating and assigned the stock a target price of $365.
On May 30, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $380. Wolfe Research Upgraded its Peer Perform to Outperform on May 13, 2025, while the target price for the stock was maintained at $350.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 21 ’25 when Benjamin Eric sold 4,263 shares for $332.23 per share. The transaction valued at 1,416,296 led to the insider holds 16,736 shares of the business.
Benjamin Eric bought 4,263 shares of PODD for $1,416,296 on Aug 21 ’25. On Aug 07 ’25, another insider, Singh Prem, who serves as the SVP, Global Operations of the company, sold 1,343 shares for $320.00 each. As a result, the insider received 429,760 and left with 4,143 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PODD now has a Market Capitalization of 24279781376 and an Enterprise Value of 24557893632. As of this moment, Insulet’s Price-to-Earnings (P/E) ratio for their current fiscal year is 104.97, and their Forward P/E ratio for the next fiscal year is 59.25. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.38. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.29 while its Price-to-Book (P/B) ratio in mrq is 16.60. Its current Enterprise Value per Revenue stands at 10.408 whereas that against EBITDA is 51.614.
Stock Price History:
The Beta on a monthly basis for PODD is 1.37, which has changed by 0.62307656 over the last 52 weeks, in comparison to a change of 0.16222072 over the same period for the S&P500. Over the past 52 weeks, PODD has reached a high of $341.14, while it has fallen to a 52-week low of $199.68. The 50-Day Moving Average of the stock is 13.12%, while the 200-Day Moving Average is calculated to be 22.00%.
Shares Statistics:
Over the past 3-months, PODD traded about 704.81K shares per day on average, while over the past 10 days, PODD traded about 540000 shares per day. A total of 70.39M shares are outstanding, with a floating share count of 70.02M. Insiders hold about 0.52% of the company’s shares, while institutions hold 101.40% stake in the company. Shares short for PODD as of 1755216000 were 1786578 with a Short Ratio of 2.53, compared to 1752537600 on 2122903. Therefore, it implies a Short% of Shares Outstanding of 1786578 and a Short% of Float of 3.8599998.
Earnings Estimates
Currently, 19.0 analysts are dedicated to thoroughly evaluating and rating the performance of Insulet Corporation (PODD) in the stock market.The consensus estimate for the next quarter is $1.33, with high estimates of $1.53 and low estimates of $1.16.
Analysts are recommending an EPS of between $4.88 and $4.45 for the fiscal current year, implying an average EPS of $4.65. EPS for the following year is $5.73, with 23.0 analysts recommending between $6.45 and $5.06.
Revenue Estimates
19 analysts predict $677.28M in revenue for the current quarter. It ranges from a high estimate of $685.71M to a low estimate of $671M. As of the current estimate, Insulet Corporation’s year-ago sales were $543.9MFor the next quarter, 19 analysts are estimating revenue of $728.21M. There is a high estimate of $745M for the next quarter, whereas the lowest estimate is $710.2M.
A total of 21 analysts have provided revenue estimates for PODD’s current fiscal year. The highest revenue estimate was $2.65B, while the lowest revenue estimate was $2.6B, resulting in an average revenue estimate of $2.62B. In the same quarter a year ago, actual revenue was $2.07BBased on 23 analysts’ estimates, the company’s revenue will be $3.09B in the next fiscal year. The high estimate is $3.19B and the low estimate is $2.98B.
